Does rituximab help in HLA desensitization for kidney transplantation?
Date
2015
Authors
Carroll, R.
Coates, P.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Kidney International, 2015; 87(2):277-279
Statement of Responsibility
Robert Carroll and P Toby Coates
Conference Name
Abstract
In the study by Jackson et al., 50 subjects were given plasma exchange and low-dose intravenous immunoglobulin to desensitize for live-donor kidney transplantation, and those deemed to have high immunological risk were also given rituximab. Transplant outcomes were similar between the two groups even though the rituximab group had higher immunological risk. These results suggest that rituximab may be helpful when added to 'standard' desensitization protocols, but definitive trials are still lacking in this area.
School/Discipline
Dissertation Note
Provenance
Description
Commentary
Access Status
Rights
© 2015 International Society of Nephrology